ZEISS and Alpenglow Biosciences partner for co-development of 3D pathology solution portfolioDynamk CapitalMay 7, 2025
Rooster Bio enters into strategic licensing agreement with Nikon Cell Innovation portfolioDynamk CapitalApril 15, 2025
Curi Bio Celebrates Grand Opening of New Global Headquarters in Seattle portfolioDynamk CapitalApril 8, 2025
Xcellbio Announces Bluebird Bio Commercial Agreement to Tackle Sickle Cell Disease portfolioDynamk CapitalApril 3, 2025
Xcell Biosciences, Royal Perth Hospital Collaboration Announcement portfolioDynamk CapitalMarch 20, 2025
bit.bio Launches ioTracker™ Cells to Revolutionize Live-Cell Imaging and Drug Discovery portfolioDynamk CapitalMarch 12, 2025
CellFE Launches First-in-Class T-REST™ Kit to Advance CAR-T Therapy Manufacturing portfolioDynamk CapitalMarch 12, 2025
Virica Biotech is Building an Ecosystem to Ramp Up AAV Production portfolioDynamk CapitalOctober 30, 2024
Lucid Scientific Highlighted by Memorial Sloan Kettering Cancer Center in The Scientist portfolioDynamk CapitalOctober 16, 2024
Alpenglow Biosciences to receive up to $21M through ARPA-H as part of the Cancer Moonshot initiative portfolioRichard FerraroAugust 19, 2024
Virica Biotech Selected as a Lead Project as Part of NIIMBL's $10M Biomanufacturing Projects portfolioDynamk CapitalApril 11, 2024
Bit.bio makes two big announcements in Alzheimer’s and Parkinson’s research and collaboration portfolioDynamk CapitalMarch 5, 2024
Curibio Leverages Their 3D Neuromuscular Junction Model for Botox Potency Assay in Collaboration with Genetox and DreamCIS portfolioDynamk CapitalFebruary 26, 2024
Portfolio company RoosterBio Announce Collaboration with Waisman Biomanufacturing For GMP Manufacturing of Cell & Exosome Therapies portfolioDynamk CapitalFebruary 7, 2024
bit.bio announces cell therapy pipeline and expanded Scientific Advisory Board portfolioDynamk CapitalNovember 13, 2023
Virica Biotech Receives Grant through Ontario Genomics’ BioCreate accelerator portfolioDynamk CapitalNovember 8, 2023
Cytiva & RoosterBio Collaborate to Address Exosome Manufacturing Challenges portfolioDynamk CapitalOctober 25, 2023
